Partnering opportunity

An artificial intelligence (AI) powered algorithm that predicts sudden cardiac arrest (SCA) from an electrocardiogram (ECG)


A UK software company has developed an AI-powered algorithm that predicts sudden cardiac arrest minutes in advance with high accuracy. They are seeking corporate partners to create new or enhance existing ECG monitoring products, leveraging their AI. Type of co-operation sought: technical co-operation, license agreement.

Partner sought

Type of partner sought: industry. Specific activity of partner sought: organisations with medical-grade ECG monitoring products. Role of partner sought: the partner will license or co-develop the product. Partners should be experienced in the healthcare field and have own products, such as device manufacturers. They should have capabilities for new product development.


A UK-based medical software company applies artificial intelligence to patient data to produce new early warning products. They are seeking to develop an early-warning system for sudden cardiac arrest (SCA). The company is seeking corporate partners to create a new or enhance an existing medical-grade ECG monitoring product. Previous work resulted in the development of a prototype algorithm that predicts SCA. This algorithm could serve as the basis for an early warning system that could alert clinicians of impending SCA and improve survival. They have filed several patents and published peer-reviewed articles. Their algorithm’s sophistication surpasses approaches in academic literature. They used a combination of cardiac datasets from hospital telemetry, Holter monitors, and implantable cardioverter defibrillators across the US, Europe and Asia. Their algorithm would trigger an alert before an arrest so that clinicians receive an opportunity to either identify and treat reversible triggers of arrhythmia, or prepare to defibrillate if the patient develops an arrest. In addition, early warning could usher in an era of research into the use of anti-arrhythmic medicines to prevent SCA. Ideally, partners would have medical-grade ECG monitoring products on the market. The algorithm will enhance existing products or support the creation of new ones. The type of co-operation would be technical co-operation and transfer of the algorithm under license.

Advantages and innovations

No other technology warns patients ahead of an oncoming episode of sudden cardiac arrest. The technology does so with a real-time risk score that is highly performant on a time scale of minutes to an hour.

Development stage

Available for demonstration

Intellectual Property Rights (IPR)

Patent(s) applied for but not yet granted

Register your interest

How it works

  • Tell us about yourself
  • We’ll discuss with you
  • We put the right partners in touch

EEN help you find the right partner, rather than you going it alone.

Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.

These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.

Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.

?What value does EEN add?
This is your pitch: remember to include your unique selling points (USP) and why someone would want to do business with you
Tell us why you are a good fit for this opportunity, and why you think you're the right people for this partnership
If there's anything additional, or commercially sensitive you'd like to know about this opportunity, please let us know

When you entered your email address above, we emailed you a code to verify you're human and have access to that account.

?What's this?

What next?

To finish up, we just need some extra details about you and your company